Opening day of the baseball season is Monday. CNBC's Brian Shactman reports on the payroll of some of the teams. Michael Ozanian of Forbes Magazine, shares his opinions.
The 10 fastest growing metro areas last year were all in red states. Art Laffer, Laffer Investments; Dean Baker, Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss.
Food stamp usage in America has gone up 70 percent since 2008. Art Laffer, Laffer Investments; Dean Baker, Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss.
CNBC's Seema Mody takes a look at how the S&P; 500 and the Dow have performed since the lows of March in 2009; and Edward Yardeni of Yardeni Research and Michael Ozanian of Forbes Magazine, weigh in.
Florida Republican Senator Marco Rubio has joined the filibuster threat over the pending gun control legislation, with Robert Costa of the National Review. Also, Rep. Peter Roskam (R-IL); Dean Baker Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss whether Republicans can overturn Obamacare.
Inventing new drugs can be a fabulous growth business, but biotech stocks represent the future of pharma, explains Mad Money host Jim Cramer. A look at Regeneron Pharmaceuticals.
Pinnacle Foods is up more than 11 percent in its first day of trading, with the "Fast Money" traders; and Ehud Gelblum of Morgan Stanley, shares his strategies to playing BlackBerry. "When gross margins go up in handset companies, stocks work," he says.
Dissecting the day's major business news, with the Fast Money traders; and Chris Verrone of Strategas, offers his strategies to playing the market. "I don't buy the argument that health care and staples are bad leadership," explains.
Q2 beings Monday, so which stocks should you get in? Chad Morganlander, Stifel Nicolaus; Sandy Villere, Villere & Co.; and Chad Deakins, Ridgeworth Capital Management, weigh in.
Church of Cyprus Archbishop Chrysostomos has thrown a wrench in the country's bailout deal, and is suing the head of the central bank and the minister of finance, reports CNBC's Michelle Caruso-Cabrera.
Investors are looking ahead to where the money can be made in Q2. Les Funtleyder, Poliwogg health care strategist and Doug Sandler, Riverfront Investment Group, provide perspective.